Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

35 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Mechanisms of disease: Oncogene addiction--a rationale for molecular targeting in cancer therapy.
Weinstein IB, Joe AK. Weinstein IB, et al. Among authors: joe ak. Nat Clin Pract Oncol. 2006 Aug;3(8):448-57. doi: 10.1038/ncponc0558. Nat Clin Pract Oncol. 2006. PMID: 16894390 Review.
17HSD 2 may be higher in African-American breast cancer and is associated with estrogen receptor-negative tumors.
Yaeger R, Nolan PC, Su T, Avila-Bront A, Wang X, Cheung YK, Liu H, Rangarajan VS, Hibshoosh H, Powell CA, Joe AK. Yaeger R, et al. Among authors: joe ak. Cancer Genomics Proteomics. 2007 Sep-Oct;4(5):341-8. Cancer Genomics Proteomics. 2007. PMID: 17993718
Prevention of bone loss after withdrawal of tamoxifen.
Cohen A, Fleischer JB, Johnson MK, Brown IN, Joe AK, Hershman DL, McMahon DJ, Silverberg SJ. Cohen A, et al. Among authors: joe ak. Endocr Pract. 2008 Mar;14(2):162-7. doi: 10.4158/EP.14.2.162. Endocr Pract. 2008. PMID: 18308653 Free PMC article. Clinical Trial.
Cyclin D1 overexpression is associated with estrogen receptor expression in Caucasian but not African-American breast cancer.
Joe AK, Memeo L, Mckoy J, Mansukhani M, Liu H, Avila-Bront A, Romero J, Li H, Troxel A, Hibshoosh H. Joe AK, et al. Anticancer Res. 2005 Jan-Feb;25(1A):273-81. Anticancer Res. 2005. PMID: 15816548
Inhibition of BCL2 expression and activity increases H460 sensitivity to the growth inhibitory effects of polyphenon E.
Borgovan T, Bellistri JP, Slack KN, Kopelovich L, Desai M, Joe AK. Borgovan T, et al. Among authors: joe ak. J Exp Ther Oncol. 2009;8(2):129-44. J Exp Ther Oncol. 2009. PMID: 20192119 Free PMC article.
(-)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cells.
Adachi S, Nagao T, To S, Joe AK, Shimizu M, Matsushima-Nishiwaki R, Kozawa O, Moriwaki H, Maxfield FR, Weinstein IB. Adachi S, et al. Among authors: joe ak. Carcinogenesis. 2008 Oct;29(10):1986-93. doi: 10.1093/carcin/bgn128. Epub 2008 Jun 26. Carcinogenesis. 2008. PMID: 18586691 Free PMC article.
Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells.
Lim JT, Joe AK, Suzui M, Shimizu M, Masuda M, Weinstein IB. Lim JT, et al. Among authors: joe ak. Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3478-84. doi: 10.1158/1078-0432.CCR-05-2051. Clin Cancer Res. 2006. PMID: 16740773
EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells.
Shimizu M, Deguchi A, Joe AK, Mckoy JF, Moriwaki H, Weinstein IB. Shimizu M, et al. Among authors: joe ak. J Exp Ther Oncol. 2005;5(1):69-78. J Exp Ther Oncol. 2005. PMID: 16416603
Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines.
Joe AK, Liu H, Suzui M, Vural ME, Xiao D, Weinstein IB. Joe AK, et al. Clin Cancer Res. 2002 Mar;8(3):893-903. Clin Cancer Res. 2002. PMID: 11895924
Exisulind and CP248 induce growth inhibition and apoptosis in human esophageal adenocarcinoma and squamous carcinoma cells.
Joe AK, Liu H, Xiao D, Soh JW, Pinto JT, Beer DG, Piazza GA, Thompson WJ, Weinstein IB. Joe AK, et al. J Exp Ther Oncol. 2003 Mar-Apr;3(2):83-94. doi: 10.1046/j.1359-4117.2003.01076.x. J Exp Ther Oncol. 2003. PMID: 12822514
35 results
Jump to page